Elan and Celgene Enter into Settlement and License Agreement Related to Abraxane - Drugs.com MedNews
Links shared publicly online about this topic.
- 480total visits
Elan and Celgene Enter into Settlement and License Agreement Related to Abraxane - Drugs.com MedNews
Feb 25, 2011 - Elan Corporation plc (NYSE ELN) and Celgene Corporation (Nasdaq CELG), today announced that Elan subsidiary Elan PharmaInternational Limited has
View full resource at drugs.com
Tags: Drug, Elan Corp.
Most Recently Shared on February 25, 2011 at 3:14 pm By:
Elan and Celgene Enter into Settlement and License Agreement Related to Abraxane: DUBLIN--(BUSINESS WIRE)-... http://bit.ly/ecjHG1 #drug
Advertisement
